Los Angeles Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

Los Angeles Capital Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,295	Closed	-$390K	–	1532
2025 Q2	$390K	Sell	8,295 -22,307	-73%	-$992K	﹤0.01%	953
2025 Q1	$1.35M	Sell	30,602 -31,158	-50%	-$1.43M	0.01%	482
2024 Q4	$2.23M	Buy	61,760 +14,548	+31%	+$508K	0.01%	432
2024 Q3	$1.51M	Buy	47,212 +33,255	+238%	+$1.24M	0.01%	526
2024 Q2	$526K	Sell	13,957 -554	-4%	-$23.3K	﹤0.01%	839
2024 Q1	$714K	Buy	+14,511	New	+$671K	﹤0.01%	784
2021 Q3	–	Sell	-2,515	Closed	-$207K	–	1589
2021 Q2	$207K	Sell	2,515 -300	-11%	-$22.8K	﹤0.01%	1490
2021 Q1	$207K	Buy	+2,815	New	+$220K	﹤0.01%	1534

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Los Angeles Capital Management's SWTX Position: Q3 2025 in Review

Los Angeles Capital Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 8,295 shares — an estimated $390K sold.

Los Angeles Capital Management first reported a position in SWTX in Q1 2021 and held it in 8 quarters. The position peaked at $2.23M in Q4 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Los Angeles Capital Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Los Angeles Capital Management sold 8,295 SpringWorks Therapeutics shares in Q3 2025, an estimated $390K.
Los Angeles Capital Management first reported a position in SpringWorks Therapeutics in Q1 2021 and held it in 8 quarters.
Los Angeles Capital Management's SpringWorks Therapeutics position peaked at $2.23M in Q4 2024.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Los Angeles Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.